Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Gastroesophageal Reflux Disease
Intervention: Drug: Esomeprazole
Sponsor: Southern Arizona VA Health Care System
Recruiting - verified January 2010
Condition: Kidney-transplant Recipients With Chronic Hepatitis E Virus Infection
Interventions: Other: blood samples and biopsy kidney; Other: blood samples and biopsy kidney
Sponsor: Assistance Publique Hopitaux De Marseille
Active, not recruiting - verified March 2010
Condition: Functional Dyspepsia
Interventions: Drug: Rabeprazole; Drug: Rabeprazole; Drug: Rabeprazole; Drug: Placebo
Sponsor: Eisai Limited
Not yet recruiting - verified March 2010
Conditions: Education of Patients; Counseling; Problem-Based Learning
Interventions: Behavioral: Celiac school; Behavioral: Usual care of celiac disease women
Sponsors: Medical Research Council of Southeast Sweden; Linkoeping University
Recruiting - verified January 2001
Condition: Hepatocellular Carcinoma
Intervention: Drug: Adjuvant group
Sponsor: Yonsei University
Completed - verified January 2009
Condition: Hepatitis D, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys]; Drug: tenofovir; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Conditions: Colonic Diseases; Bowel Diseases
Intervention: Device: PillCam™ (Capsule Endoscopy) Colon 2 capsule
Sponsor: Given Imaging Ltd.
Active, not recruiting - verified March 2010
Conditions: Small Bowel Disease; Inflammatory Bowel Disease
Intervention: Device: PillCam® Express Capsule Endoscopy Delivery System
Sponsor: Given Imaging Ltd.
Recruiting - verified March 2010
Condition: Pancreatic Disease
Interventions: Drug: ChiRhoStim; Drug: Placebo
Sponsor: ChiRhoClin, Inc.
Completed - verified March 2010
Condition: Colorectal Neoplasms
Interventions: Drug: Glutamine; Drug: Calcium and Magnesium
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Colorectal Cancer
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Ulcerative Colitis
Intervention: Drug: Cimzia
Sponsors: University of Washington; UCB, Inc.; University of Pennsylvania
Not yet recruiting - verified March 2010
Condition: Advanced Gastric Cancer
Interventions: Procedure: laparoscopy assisted distal gastrectomy; Procedure: open distal gastrectomy
Sponsor: National Cancer Center, Korea
Not yet recruiting - verified March 2010
Condition: Compensated Chronic Hepatitis B
Interventions: Drug: lamivudine; Drug: lamivudine; Drug: lamivudine, adefovir
Sponsors: Nanfang Hospital; Ministry of Health, China; GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Bladder Cancer; Cervical Cancer; Colorectal Cancer; Endometrial Cancer; Gastrointestinal Complications; Long-term Effects Secondary to Cancer Therapy in Adults; Ovarian Cancer; Prostate Cancer; Radiation Toxicity; Sarcoma; Testicular Germ Cell Tumor; Vaginal Cancer
Interventions: Other: questionnaire administration; Procedure: gastrointestinal complications management/prevention; Procedure: quality-of-life assessment
Sponsor: Royal Marsden NHS Foundation Trust
Recruiting - verified March 2010
Condition: Crohn´s Disease
Interventions: Drug: budesonide; Drug: budesonide
Sponsor: Dr. Falk Pharma GmbH
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: systemic chemotherapy; Procedure: adjuvant therapy; Procedure: quality-of-life assessment; Procedure: therapeutic conventional surgery
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Conditions: Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms
Intervention: Behavioral: Psychosocial rehabilitation course
Sponsors: Danish Cancer Society; University Hospital Århus, Department of Surgery; University Hospital Århus, Urology Department; Regional Hospital Randers, Department of Colorectal Surgery; Regional Hospital Hørsholm, Department of Breast Surgery
Completed - verified March 2010
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA) withdrawal and reinstitution
Sponsors: University of Tennessee; Mount Sinai School of Medicine; Children's Memorial Hospital; University of California, San Francisco; The Hospital for Sick Children; University of Colorado, Denver; Children's Hospital Medical Center, Cincinnati; University of Pittsburgh
Not yet recruiting - verified March 2010
Conditions: Cystic Fibrosis; Rhinosinusitis
Interventions: Drug: NaCl 6%; Drug: NaCl 0,9%
Sponsor: University of Jena
Not yet recruiting - verified March 2010
Condition: Mucositis
Intervention: Drug: Doxycycline hyclate
Sponsors: Metropolitan Autonomous University; Instituto Nacional de Cancerologia de Mexico
Not yet recruiting - verified March 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: BMS-908662; Drug: BMS-908662; Drug: Cetuximab
Sponsors: Bristol-Myers Squibb; Genzyme
Not yet recruiting - verified March 2010
Condition: Constipation-predominant Irritable Bowel Syndrome
Intervention: Drug: Lubiprostone
Sponsors: Cedars-Sinai Medical Center; Takeda Pharmaceuticals North America, Inc.
Not yet recruiting - verified December 2009
Condition: Pancreatic Neoplasms
Intervention: Drug: Nelfinavir
Sponsors: University of Iowa; Holden Comprehensive Cancer Center
Recruiting - verified March 2010
Conditions: Leukemia; Mucositis; Oral Complications
Interventions: Biological: epratuzumab; Biological: palifermin; Biological: rituximab; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: etoposide; Drug: fludarabine phosphate; Drug: imatinib mesylate; Drug: melphalan; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: assessment of therapy complications; Radiation: total-body irradiation
Sponsor: University College London Hospitals
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Other: Observational Study
Sponsors: Bristol-Myers Squibb; AstraZeneca; University of Pennsylvania
Active, not recruiting - verified March 2010
Condition: Hepatitis B, Chronic
Interventions: Drug: peginterferon alfa-2a [PEGASYS]; Drug: peginterferon alfa-2a [PEGASYS]; Drug: Adefovir
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
Condition: Rotavirus Gastroenteritis
Interventions: Biological: Placebo; Biological: Rotarix ™
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Vancomycin; Drug: Vancomycin; Drug: Metronidazole; Drug: Metronidazole; Drug: Vancomycin
Sponsors: Mayo Clinic; PSC Partners Seeking a Cure Foundation
Recruiting - verified March 2010
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Drug: Metformin
Sponsor: Wolfson Medical Center
Completed - verified March 2010
Conditions: Neglect; Dysphagia
Interventions: Drug: Modafinil; Drug: Placebo
Sponsors: University of Arkansas; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer Screening
Intervention: Behavioral: Tailored interactive intervention to increasing CRCS
Sponsors: The University of Texas Health Science Center, Houston; National Cancer Institute (NCI)
Completed - verified March 2010
Condition: Barrett's Esophagus
Intervention:
Sponsor: Mayo Clinic
Enrolling by invitation - verified March 2010
Condition: Chronic Hepatitis C
Interventions: Drug: peginterferon alfa-2a [Pegasys]; Device: autoinjector; Device: pre-filled syringe
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified March 2010
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Galvus (vitagliptin); Drug: Galvus + vitamin D
Sponsor: Ziv Hospital
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Oral Mucositis
Interventions: Drug: amlexanox; Drug: Vehicle rinse
Sponsors: Access Pharmaceuticals, Inc.; Advanced Clinical Research Services, LLC
Completed - verified March 2010
Conditions: Biliary Stricture; Chronic Pancreatitis
Intervention:
Sponsors: Helsinki University Central Hospital; University of Turku; Oulu University Hospital
Recruiting - verified January 2010
Condition: Irritable Bowel Syndrome
Interventions: Dietary Supplement: Duolac7S; Dietary Supplement: starch
Sponsor: Cell Biotech Co., Ltd.
Recruiting - verified March 2010
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: Gemcitabine, nab-Paclitaxel, GDC-0449
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Stand Up To Cancer; Genentech; Abraxis BioScience Inc.
Not yet recruiting - verified March 2010
Conditions: Liver Fibrosis; Liver Cirrhosis; Viral Hepatitis; Liver Tumour; Cardiac Failure; Biliary Cholestasis.
Interventions: Device: ARFI measurement; Device: ARFI measurement; Device: ARFI measurement
Sponsor: University Hospital, Bordeaux
Not yet recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: iodinated contrast dye; Drug: motexafin gadolinium; Other: laboratory biomarker analysis
Sponsors: American College of Radiology Imaging Network; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Interventions: Drug: TOBI; Drug: Placebo to TOBI
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Conditions: Advanced Gastric Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: AUY922; Drug: Docetaxel or Irinotecan
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified March 2010
Conditions: Diarrhea; Dysentery (Bloody Diarrhea)
Intervention: Other: Solar disinfection in transparent containers (plastic bottles)
Sponsors: Council for Scientific and Industrial Research, South Africa; Royal College of Surgeons, Ireland; European Union
Completed - verified June 2009
Condition: Small Bowel Obstruction
Interventions: Drug: Somatostatin; Other: common daily practice
Sponsor: Nanjing PLA General Hospital
Not yet recruiting - verified February 2010
Conditions: Heart Disease; Liver Failure; Depressive Disorder; Alcoholic Neuropathy
Intervention: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Sponsor: Levanger Hospital
Recruiting - verified January 2010
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Mek Inhibitor MSC1936369B; Drug: Mek Inhibitor MSC1936369B; Drug: Placebo; Drug: FOLFIRI
Sponsor: EMD Serono
Recruiting - verified March 2010
Condition: Hepatitis C
Interventions: Drug: ABT-072; Drug: Placebo
Sponsors: Abbott; Abbott Japan Co.,Ltd
Recruiting - verified March 2010
Condition: Liver Cirrhosis
Intervention:
Sponsor: Maastricht University Medical Center
Not yet recruiting - verified March 2010
Conditions: Cognitive/Functional Effects; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Drug: systemic chemotherapy; Other: questionnaire administration; Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: quality-of-life assessment
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention: Drug: Erbitux (Cetuximab)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Esophageal Intubation
Interventions: Other: Description of the pressure waveforms during tracheal ventilation; Other: Description of the pressure waveforms during esophageal ventilation
Sponsor: University Medical Centre Groningen
Recruiting - verified October 2009
Condition: Hepatitis B Virus
Interventions: Drug: Peginterferon + Vitamin D; Drug: Peginterferon; Drug: Sebivo
Sponsor: Ziv Hospital
Not yet recruiting - verified March 2010
Condition: Hepatitis C, Chronic
Interventions: Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron); Drug: Drug: SCH 900518 Biologic: Peginterferon alfa-2b; Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron); Drug: Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)
Sponsor: Schering-Plough
Completed - verified March 2010
Condition: Colorectal Cancer
Interventions: Biological: cetuximab; Biological: ramucirumab; Drug: irinotecan hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: GERD
Intervention: Drug: esomeprazole 40 mg
Sponsors: Digestive & Liver Disease Specialists; AstraZeneca
Recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Drug: Gemcitabine and Pazopanib
Sponsor: Washington University School of Medicine
Not yet recruiting - verified March 2010
Condition: Liver Cancer
Interventions: Drug: temsirolimus; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: quality-of-life assessment; Radiation: fludeoxyglucose F 18
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified March 2010
Condition: Peptic Ulcer
Intervention: Device: Endoscopic Translumenal Omental Patch
Sponsor: Mayo Clinic
Not yet recruiting - verified March 2010
Condition: Chronic Hepatitis B Virus, Pediatric
Interventions: Drug: Entecavir; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified March 2010
Condition: Cirrhosis
Intervention: Other: Critical flicker frequency procedure
Sponsor: University Hospital, Toulouse
Recruiting - verified March 2010
Conditions: Crohn's Disease; Ulcerative Colitis
Interventions: Dietary Supplement: probiotics; Dietary Supplement: placebo
Sponsors: The Baruch Padeh Medical Center, Poriya; Ministry of Health, Israel
Not yet recruiting - verified March 2010
Condition: Esophageal Varices
Intervention: Device: Capsule endoscopy, Esophagogastroduodenoscopy
Sponsors: University of California, Los Angeles; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified June 2008
Conditions: Length of Stay; Complications; Adverse Drug Event; Quality of Life; Hospital Costs
Interventions: Procedure: Laparoscopic Surgery for Colorectal Cancer; Drug: XELOX Chemotherapy; Drug: mFolfox6 chemotherapy; Other: Fast Track Perioperative Treatment; Other: Conventional Perioperative Treatment; Procedure: Open Surgery for Colorectal Cancer
Sponsor: Zhejiang University
Not yet recruiting - verified March 2010
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: telaprevir; Drug: VX-222; Drug: ribavirin; Biological: peginterferon-alfa-2a; Drug: VX-222
Sponsor: Vertex Pharmaceuticals Incorporated
Not yet recruiting - verified March 2010
Condition: Hepatic Dysfunction in Critically Ill Patients
Interventions: Device: Hepa Wash; Procedure: Standard Medical Therapy
Sponsor: Hepa Wash GmbH
Not yet recruiting - verified March 2010
Condition: Pancreatic Cancer
Intervention: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - verified March 2010
Condition: Hepatocellular Cancer
Intervention:
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Conditions: Ovarian Cancer; Bowel Obstruction
Interventions: Drug: Cisplatin; Drug: Paclitaxel
Sponsor: University Health Network, Toronto
Recruiting - verified February 2010
Condition: Colitis, Ischemic
Intervention:
Sponsors: University of California, Los Angeles; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified December 2009
Condition: Acute-on-chronic Liver Failure
Interventions: Device: Hepa Wash; Procedure: Standard Medical Therapy
Sponsor: Hepa Wash GmbH
Not yet recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: capecitabine [Xeloda]; Drug: oxaliplatin
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Crohn´s Disease
Intervention: Biological: adalimumab (Humira)
Sponsor: Abbott
Recruiting - verified March 2010
Condition: Esophageal Cancer
Intervention:
Sponsors: Merck; World Health Information Science Consultants, LLC
Active, not recruiting - verified February 2010
Condition: Colorectal Neoplasms
Interventions: Behavioral: Stepped CRCS Interventions; Behavioral: Control
Sponsors: The University of Texas Health Science Center, Houston; Duke University; Boston University
Recruiting - verified March 2010
Condition: Carcinoma, Hepatocellular
Intervention: Device: Ablation with the NanoKnife Irreversible Electroporation (IRE) System
Sponsor: Angiodynamics, Inc.
Recruiting - verified March 2010
Condition: Cystic Fibrosis
Intervention:
Sponsors: CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Recruiting - verified March 2010
Conditions: Heart Disease; Dyspnea; Aortic Disease; Kidney Disease; Liver Disease
Intervention: Other: Ultrasound examination
Sponsors: Levanger Hospital; Norwegian University of Science and Technology
Recruiting - verified February 2010
Condition: Gastroesophageal Reflux Disease
Intervention:
Sponsor: Nationwide Children's Hospital
Not yet recruiting - verified February 2010
Conditions: Squamous Cell Carcinoma; Adenocarcinoma; Esophageal Cancer; Gastro-esophageal Junction Cancer
Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Panitumumab; Radiation: 3-D conformal radiation
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified July 2009
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Capecitabine; Drug: Cetuximab; Drug: Everolimus
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified October 2009
Condition: Type 2 Diabetes
Interventions: Drug: exenatide; Drug: Other antidiabetic therapies; Other: No diabetes therapy
Sponsors: Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Completed - verified February 2010
Conditions: Squamous Cell Carcinoma of the Oral Cavity; Oropharynx Metastases; Lymph Metastases
Interventions: Procedure: endoscopic examination; Procedure: FDG-PET
Sponsor: University Hospital, Ghent
Recruiting - verified March 2010
Condition: Chronic Calculous Cholecystitis
Interventions: Procedure: Laparoscopic cholecystectomy; Procedure: Open Surgery
Sponsors: Ministry of Health, Montenegro; Medical School of Podgorica, Montenegro; General Hospital Berane, Montenegro
Completed - verified February 2010
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Procedure: Immunochemical fecal occult blood test And colonoscopy if test is positive; Procedure: Colonoscopy with sedation
Sponsor: Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Recruiting - verified September 2008
Condition: Liver Cancer
Interventions: Drug: pravastatin; Drug: sorafenib tosylate; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Procedure: quality-of-life assessment
Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting - verified February 2010
Condition: Liver Cancer
Intervention: Device: Theraspheres
Sponsors: Stanford University; MDS Nordion, Inc.
Available - verified February 2010
Conditions: Peritonitis; Malnutrition
Interventions: Drug: Pro-biotics; Dietary Supplement: Oligosaccharide
Sponsors: National Cheng-Kung University Hospital; PRO-BIO BIOTECH.CO.,LTD.
Recruiting - verified February 2010
Condition: Crohn's Disease
Intervention:
Sponsors: Haukeland University Hospital; University of Bergen; Abbott
Recruiting - verified February 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Genetic: gene expression analysis; Genetic: polymorphism analysis; Genetic: protein expression analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Head and Neck Cancer; Lung Cancer; Liver Cancer; Rectal Cancer; Cervical Cancer
Intervention: Drug: [F 18]HX4
Sponsor: Siemens Molecular Imaging
Recruiting - verified February 2010
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Interventions: Biological: pegfilgrastim; Drug: bortezomib; Drug: carboplatin; Other: pharmacological study
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Condition: Advanced Pancreatic Cancer
Intervention:
Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Not yet recruiting - verified February 2010
Condition: Clostridium Difficile Infection
Interventions: Drug: MIYA-BM Fine Granules (CBM588); Drug: Placebo Fine Granules (without CBM588)
Sponsor: Osel, Inc.
Recruiting - verified February 2010
Conditions: Hepatic Metastases; Colorectal Cancer
Intervention: Procedure: Routine hilar lymphadenectomy
Sponsor: University of Heidelberg
Enrolling by invitation - verified February 2010
Condition: Colorectal Cancer
Intervention: Dietary Supplement: vitamin D repletion with Cholecalciferol (vitamin D3 50,000 International Units)
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010
Condition: Colorectal Neoplasm
Intervention: Drug: Cetuximab
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Stage IV Colorectal Cancer; Dignity Therapy
Intervention: Behavioral: Dignity Therapy
Sponsor: Northwestern University
Not yet recruiting - verified February 2010
Conditions: Metastatic Renal Cell Carcinoma; Gastrointestinal Stromal Tumors
Intervention: Drug: Sunitinib malate
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Hepatitis C Recurrence
Intervention: Drug: Nitazoxanide
Sponsor: Mayo Clinic
Recruiting - verified February 2010
Condition: Hepatitis C, HCV, Chronic Hepatitis C, Hepatitis C Genotype 1
Interventions: Drug: ABT-450; Drug: ABT-072; Drug: ABT-333; Drug: ritonavir; Drug: pegIFN; Drug: ribavirin
Sponsor: Abbott
Not yet recruiting - verified February 2010
Conditions: Acute on Chronic Liver Failure; Hepatitis B
Intervention: Drug: Tenofovir disoproxil fumarate (TDF)
Sponsor: Govind Ballabh Pant Hospital
Completed - verified October 2009
Condition: Gastroenteritis Rotavirus
Intervention:
Sponsor: Merck
Recruiting - verified February 2010
Condition: Diabetes in Cystic Fibrosis Patients
Intervention: Other: Prospective cohort with an annual follow-up
Sponsor: Hospices Civils de Lyon
Recruiting - verified October 2009
Condition: HCV Infection
Interventions: Drug: GS-9256; Drug: GS-9190; Drug: Ribavirin
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Enteritis
Intervention: Drug: DOR201 (delayed release beclomethasone dipropionate)
Sponsors: Soligenix; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Liver Cancer
Interventions: Drug: sorafenib tosylate; Drug: vorinostat
Sponsors: Virginia Commonwealth University; Massey Cancer Center
Not yet recruiting - verified March 2010
Conditions: Cirrhosis; Liver Fibrosis; Portal Hypertension; Cystic Fibrosis; Parenteral Nutrition
Intervention: Other: Elastometry
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010
Conditions: Inflammation; Colon, Irritable; Colonic Diseases, Functional; Irritable Bowel Syndrome
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Colorectal Cancer
Interventions: Behavioral: Multimedia Education; Behavioral: Print Media; Behavioral: Usual and customary waiting room process
Sponsors: Saint Francis Care; American Cancer Society; Feinberg School of Medicine, Northwestern University
Recruiting - verified February 2010
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute-Pancreatic Cancer Vaccine
Sponsor: NewLink Genetics Corporation
Not yet recruiting - verified February 2010
Condition: Colon, Irritable
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Gastroparesis
Interventions: Drug: [2-13C] uracil; Drug: [2-13C] uracil, placebo
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified February 2010
Condition: Liver Cirrhosis
Intervention:
Sponsors: University College London Hospitals; Medical Research Council
Recruiting - verified April 2008
Conditions: Inappetence; Deficiency of Growth (Children); Deficiency of Weight Gain, and; Vitamin Deficiencies
Intervention: Drug: Apetiviton BC
Sponsor: Cifarma Cientifica Farmaceutica Ltda
Not yet recruiting - verified March 2009
Condition: Anorexia Nervosa
Interventions: Drug: aripiprazole; Drug: placebo
Sponsor: Hospital Clinic of Barcelona
Not yet recruiting - verified March 2010
All Categories ... Medical Conditions » ... Fibromyalgia » ... Symptom: Digestive disorder 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
